Antonio Gualberto

2PUBLICATIONS
24CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.

David P Steensma, Martin Wermke, Virginia M Klimek

|Mar 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.

Alan L Ho, Irene Brana, Robert Haddad

Pageof 1